Brief: Oramed Pharmaceuticals Announces Restructuring Of Scilex Holding Company Debt
07/10/2024 15:30
Oct 7 (Reuters) - Oramed Pharmaceuticals Inc ORMP.O :
* ORAMED PHARMACEUTICALS ANNOUNCES RESTRUCTURING OF SCILEX
HOLDING
COMPANY DEBT
* ORAMED PHARMACEUTICALS INC - TO RESTRUCTURE $22.5 MILLION
OF
SCILEX'S DEBT
* ORAMED PHARMACEUTICALS INC - TO RECEIVE $25 MILLION NOTE
WITH
5.5% INTEREST
Source text for Eikon: ID:nPnp2n0Za
Further company coverage: ORMP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oramed Pharmaceuticals
See all newsBrief: Nano Dimension Appoints Nadav Kidron To Board Of Directors To Chair Strategy And Capital Allocation Committee
Oramed Pharmaceuticals Inc expected to post earnings of 43 cents a share - Earnings Preview
Brief: Oramed And Lifeward Announce Strategic Transaction
Brief: Oramed Receives $18 Million Payment From Scilex Holdings
Brief: Oramed Reports Fiscal Third Quarter 2025 Financial Results